5,7,3′,4′-Tetramethoxyflavone suppresses TGF-β1-induced activation of murine fibroblasts in vitro and ameliorates bleomycin-induced pulmonary fibrosis in mice

References

• Divya T, Velavan B, Sudhandiran G. Regulation of transforming growth factor-beta/Smad-mediated epithelial-mesenchymal transition by celastrol provides protection against bleomycin-induced pulmonary fibrosis. Basic Clin Pharmacol Toxicol. 2018;123(2):122–129. doi: 10.1111/bcpt.12975.
   PubMed Web of Science ®Google Scholar
• Du Bois RM. An earlier and more confident diagnosis of idiopathic pulmonary fibrosis. Eur Respir Rev. 2012;21(124):141–146. doi: 10.1183/09059180.00000812.
   PubMedGoogle Scholar
• Sauleda J, Núñez B, Sala E, et al. Idiopathic pulmonary fibrosis: epidemiology, natural history, phenotypes. Med Sci. 2018;6(4):110. doi: 10.3390/medsci6040110.
   Google Scholar
• Selvaggio AS, Noble PW. Pirfenidone initiates a new era in the treatment of idiopathic pulmonary fibrosis. Annu Rev Med. 2016;67(1):487–495. doi: 10.1146/annurev-med-120214-013614.
   PubMed Web of Science ®Google Scholar
• Richeldi L, Du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2071–2082. doi: 10.1056/NEJMoa1402584.
   PubMed Web of Science ®Google Scholar
• Raghu G, Rochwerg B, Zhang Y, et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015;192(2):e3–e19. doi: 10.1164/rccm.201506-1063ST.
   PubMed Web of Science ®Google Scholar
• Wang Q, Xie ZL, Wu Q, et al. Role of various imbalances centered on alveolar epithelial cell/fibroblast apoptosis imbalance in the pathogenesis of idiopathic pulmonary fibrosis. Chin Med J (Engl). 2021;134(3):261–274. doi: 10.1097/CM9.0000000000001288.
   PubMed Web of Science ®Google Scholar
• Sime PJ, Xing Z, Graham FL, et al. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest. 1997;100(4):768–776. doi: 10.1172/JCI119590.
   PubMed Web of Science ®Google Scholar
• Fernandez IE, Eickelberg O. The impact of TGF-beta on lung fibrosis: from targeting to biomarkers. Proc Am Thorac Soc. 2012;9(3):111–116. doi: 10.1513/pats.201203-023AW.
   PubMedGoogle Scholar
• Luzina IG, Todd NW, Sundararajan S, et al. The cytokines of pulmonary fibrosis: much learned, much more to learn. Cytokine. 2015;74(1):88–100. doi: 10.1016/j.cyto.2014.11.008.
   PubMed Web of Science ®Google Scholar
• Todd NW, Luzina IG, Atamas SP. Molecular and cellular mechanisms of pulmonary fibrosis. Fibrogenesis Tissue Repair. 2012;5(1):11. doi: 10.1186/1755-1536-5-11.
   PubMedGoogle Scholar
• Jarman ER, Khambata VS, Cope C, et al. An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model. Am J Respir Cell Mol Biol. 2014;50(1):158–169. doi: 10.1165/rcmb.2013-0174OC.
   PubMed Web of Science ®Google Scholar
• Venkatesan N, Pini L, Ludwig MS. Changes in Smad expression and subcellular localization in bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2004;287(6):L1342–7. doi: 10.1152/ajplung.00035.2004.
   PubMed Web of Science ®Google Scholar
• Hong M, Wilkes MC, Penheiter SG, et al. Non-Smad transforming growth factor-beta signaling regulated by focal adhesion kinase binding the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem. 2011;286(20):17841–17850. doi: 10.1074/jbc.M111.233676.
   PubMed Web of Science ®Google Scholar
• Wilkes MC, Mitchell H, Penheiter SG, et al. Transforming growth factor-beta activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-activated kinase-2. Cancer Res. 2005;65(22):10431–10440. doi: 10.1158/0008-5472.CAN-05-1522.
   PubMed Web of Science ®Google Scholar
• Zhang YE. Non-Smad pathways in TGF-beta signaling. Cell Res. 2009;19(1):128–139. doi: 10.1038/cr.2008.328.
   PubMed Web of Science ®Google Scholar
• Luo F, Zhuang Y, Sides MD, et al. Arsenic trioxide inhibits transforming growth factor-beta1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo. Respir Res. 2014;15(1):51. doi: 10.1186/1465-9921-15-51.
   PubMedGoogle Scholar
• Itoh S, Itoh F, Goumans MJ, et al. Signaling of transforming growth factor-beta family members through Smad proteins. Eur J Biochem. 2000;267(24):6954–6967. doi: 10.1046/j.1432-1327.2000.01828.x.
   PubMedGoogle Scholar
• Da C, Liu Y, Zhan Y, et al. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-beta1/Smad3 signaling pathway. Oncol Rep. 2016;35(5):2767–2774. doi: 10.3892/or.2016.4661.
   PubMed Web of Science ®Google Scholar
• Chen KH, Weng MS, Lin JK. Tangeretin suppresses IL-1beta-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells. Biochem Pharmacol. 2007;73(2):215–227. doi: 10.1016/j.bcp.2006.09.018.
   PubMed Web of Science ®Google Scholar
• Horigome S, Yoshida I, Ito S, et al. Inhibitory effects of Kaempferia parviflora extract on monocyte adhesion and cellular reactive oxygen species production in human umbilical vein endothelial cells. Eur J Nutr. 2017;56(3):949–964. doi: 10.1007/s00394-015-1141-5.
   PubMed Web of Science ®Google Scholar
• Wu L, Liu H, Li L, et al. 5,7,3’,4’-Tetramethoxyflavone exhibits chondroprotective activity by targeting beta-catenin signaling in vivo and in vitro. Biochem Biophys Res Commun. 2014;452(3):682–688. doi: 10.1016/j.bbrc.2014.08.129.
   PubMed Web of Science ®Google Scholar
• Huang X, Chen Z, Shi W, et al. TMF inhibits miR-29a/Wnt/beta-catenin signaling through upregulating Foxo3a activity in osteoarthritis chondrocytes. Drug Des Devel Ther. 2019;13:2009–2019. doi: 10.2147/DDDT.S209694.
   PubMed Web of Science ®Google Scholar
• Mucenski ML, Nation JM, Thitoff AR, et al. Beta-catenin regulates differentiation of respiratory epithelial cells in vivo. Am J Physiol Lung Cell Mol Physiol. 2005;289(6):L971–L979. doi: 10.1152/ajplung.00172.2005.
   PubMed Web of Science ®Google Scholar
• Königshoff M, Balsara N, Pfaff E-M, et al. Functional Wnt signaling is increased in idiopathic pulmonary fibrosis. PLOS One. 2008;3(5):e2142. doi: 10.1371/journal.pone.0002142.
   PubMed Web of Science ®Google Scholar
• Akhmetshina A, Palumbo K, Dees C, et al. Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis. Nat Commun. 2012;3(1):735. doi: 10.1038/ncomms1734.
   PubMedGoogle Scholar
• Xu L, Cui WH, Zhou WC, et al. Activation of Wnt/beta-catenin signalling is required for TGF-beta/Smad2/3 signalling during myofibroblast proliferation. J Cell Mol Med. 2017;21(8):1545–1554. doi: 10.1111/jcmm.13085.
   PubMed Web of Science ®Google Scholar
• Al-Tamari HM, Dabral S, Schmall A, et al. FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis. EMBO Mol Med. 2018;10(2):276–293. doi: 10.15252/emmm.201606261.
   PubMed Web of Science ®Google Scholar
• Cao H, Wang C, Chen X, et al. Inhibition of Wnt/beta-catenin signaling suppresses myofibroblast differentiation of lung resident mesenchymal stem cells and pulmonary fibrosis. Sci Rep. 2018;8(1):13644. doi: 10.1038/s41598-018-28968-9.
   PubMedGoogle Scholar
• Hübner R-H, Gitter W, El Mokhtari NE, et al. Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques. 2008;44(4):507–517. doi: 10.2144/000112729.
   PubMed Web of Science ®Google Scholar
• Willis BC, Borok Z. TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol. 2007;293(3):L525–L534. doi: 10.1152/ajplung.00163.2007.
   PubMed Web of Science ®Google Scholar
• King TE, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2083–2092. doi: 10.1056/NEJMoa1402582.
   PubMed Web of Science ®Google Scholar
• Rangarajan S, Kurundkar A, Kurundkar D, et al. Novel mechanisms for the antifibrotic action of nintedanib. Am J Respir Cell Mol Biol. 2016;54(1):51–59. doi: 10.1165/rcmb.2014-0445OC.
   PubMed Web of Science ®Google Scholar
• Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J. 2004;18(7):816–827. doi: 10.1096/fj.03-1273rev.
   PubMed Web of Science ®Google Scholar
• Huang F, Chen YG. Regulation of TGF-beta receptor activity. Cell Biosci. 2012;2(1):9. doi: 10.1186/2045-3701-2-9.
   PubMedGoogle Scholar
• Kato K, Hecker L. NADPH oxidases: pathophysiology and therapeutic potential in age-associated pulmonary fibrosis. Redox Biol. 2020;33:101541. doi: 10.1016/j.redox.2020.101541.
   PubMed Web of Science ®Google Scholar
• Richter K, Konzack A, Pihlajaniemi T, et al. Redox-fibrosis: impact of TGFbeta1 on ROS generators, mediators and functional consequences. Redox Biol. 2015;6:344–352. doi: 10.1016/j.redox.2015.08.015.
   PubMed Web of Science ®Google Scholar
• Chilosi M, Poletti V, Zamò A, et al. Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol. 2003;162(5):1495–1502. doi: 10.1016/s0002-9440(10)64282-4.
   PubMed Web of Science ®Google Scholar
• Lam AP, Herazo-Maya JD, Sennello JA, et al. Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2014;190(2):185–195. doi: 10.1164/rccm.201401-0079OC.
   PubMed Web of Science ®Google Scholar
• Zhou B, Liu Y, Kahn M, et al. Interactions between beta-catenin and transforming growth factor-beta signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP). J Biol Chem. 2012;287(10):7026–7038. doi: 10.1074/jbc.M111.276311.
   PubMed Web of Science ®Google Scholar
• Königshoff M, Kramer M, Balsara N, et al. WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest. 2009;119(4):772–787. doi: 10.1172/JCI33950.
   PubMed Web of Science ®Google Scholar
• Wei J, Fang F, Lam AP, et al. Wnt/beta-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells. Arthritis Rheum. 2012;64(8):2734–2745. doi: 10.1002/art.34424.
   PubMedGoogle Scholar
• Wu L, Liu H, Li L, et al. 5,7,3’,4’-Tetramethoxyflavone protects chondrocytes from ER stress-induced apoptosis through regulation of the IRE1alpha pathway. Connect Tissue Res. 2018;59(2):157–166. doi: 10.1080/03008207.2017.1321639.
   PubMed Web of Science ®Google Scholar
• Peng F, Huang X, Shi W, et al. 5,7,3’,4’-tetramethoxyflavone ameliorates cholesterol dysregulation by mediating SIRT1/FOXO3a/ABCA1 signaling in osteoarthritis chondrocytes. Future Med Chem. 2021;13(24):2153–2166. doi: 10.4155/fmc-2021-0247.
   PubMed Web of Science ®Google Scholar